به جمع مشترکان مگیران بپیوندید!

تنها با پرداخت 70 هزارتومان حق اشتراک سالانه به متن مقالات دسترسی داشته باشید و 100 مقاله را بدون هزینه دیگری دریافت کنید.

برای پرداخت حق اشتراک اگر عضو هستید وارد شوید در غیر این صورت حساب کاربری جدید ایجاد کنید

عضویت

جستجوی مقالات مرتبط با کلیدواژه "alpha-thalassemia" در نشریات گروه "پزشکی"

  • محسن میرزاخانی، محمدجواد طراحی، عاطفه باقرصاد، محمدرضا مرآثی*
    مقدمه

    در دستورالعمل غربالگری بتا تالاسمی ایران زوجین با اندکس خونی 3 > HbF و 3/5> HbA2، 27-26 = MCH، 80-75 = MCV به عنوان زوج مشکوک کم خطر طبقه بندی می شوند و انجام آزمایشات ژنتیک در این زوجین اجباری نمی باشد. اگر شاخص های خونی افراد ناقل آلفا تالاسمی (دارای 1 حذف یا 2 حذف ژن آلفا) در محدوده ی زوج کم خطر باشد در برنامه ی غربالگری بتاتالاسمی قادر به شناسایی این زوجین نخواهیم بود ولی در صورتی که شاخص های خونی ناقلین آلفا تالاسمی در محدوده ی زوج مشکوک پرخطر باشد با دستورالعمل غربالگری بتاتالاسمی امکان شناسایی این زوجین امکان پذیر خواهد بود.

    روش ها

    در این مطالعه ی مقطعی با استفاده از نتیجه آزمایش PND اطلاعات 2359 فرد مبتلا به آلفا تالاسمی که طی سال های 1400-1397 در 22 مرکز مشاور ازدواج استان اصفهان شناسایی شده اند، استخراج شد و شاخص های خونی MCV, MCH افراد ناقل الفا تالاسمی با مقادیر زوج کم خطر و پر خطر زوج ناقل بتا تالاسمی مقایسه شد.

    یافته ها

    میانگین  MCHو MCV زوجین مبتلا به 1 و 2 حذف ژن آلفا تالاسمی به تر تیب در محدوده ی زوج کم خطر و پر خطر بتا تالاسمی می باشد.

    نتیجه گیری

    دستورالعمل غربالگری بتاتالاسمی قادر به شناسایی افراد دارای 2 حذف ژن آلفا تالاسمی می باشد در صورتی که این دستورالعمل در شناسایی افراد دارای 1 حذف ژن آلفا کارآیی ندارد. بنابراین می توان گفت با دستورالعمل حال حاضر می توان از بروز و عوارض بارداری در مادران دارای نوزاد هموگلوبین بارت پیشگیری نمود، ولی شناسایی بیماری هموگلوبین H امکان پذیر نیست.

    کلید واژگان: آلفا تالاسمی, بتا تالاسمی, هیدروپس فتالیس, هموگلوبین H
    Mohsen Mirzakhani, Mohammadjavad Tarrahi, Atefe Baghersad, Mohammadreza Maracy *
    Background

    Thalassemia screening instructions in Iran consider couples with MCV = 75-80, MCH = 26-27, HbA2<3.5, and HbF<3 indices as low-risk couples, and therefore further genetic testing is not obligatory. If the blood indices of alpha thalassemia carriers (One alpha gene deletion or two alpha gene deletions) fall within the parameters of low-risk couples, the identification of such couples within the beta thalassemia screening program will not be feasible. However, if the blood indicators of alpha thalassemia carriers fall within the range of the suspected high-risk couple, these couples can be identified through beta thalassemia screening instructions.

    Methods

    In this cross-sectional study, information was extracted from 2359 individuals diagnosed with alpha thalassemia, identified between 2018 and 2021, in 22 marriage counseling centers in Isfahan province using the results of the PND test. The blood indices MCV and MCH of alpha thalassemia carriers were compared with the low-risk and high-risk values of beta thalassemia carrier couples.

    Findings

    The average MCH and MCV of couples affected by alpha thalassemia gene deletions 1 and 2 are respectively within the low-risk and high-risk ranges for beta-thalassemia.

    Conclusion

    Beta thalassemia screening guidelines can effectively identify individuals with two alpha thalassemia gene deletions, although they have no effect in identifying those with one alpha gene deletion. Current guidelines indicate that it is possible to prevent the occurrence and complications of pregnancy in mothers with Bart's hemoglobin infants; however, the identification of H hemoglobin disease remains unfeasible.

    Keywords: Alpha Thalassemia, Beta Thalassemia, Hydrops Fetalis, Hemoglobin H
  • Pourya Farhangi, Minoo Hajmiri, Nooshin Shirzad, Mahboobeh Hemmatabadi

    Hereditary hemochromatosis (HH) is a rare genetic disorder, causing systemic iron overload. High amounts of iron in the bloodstream gradually oversaturate the trans- ferrin which can cause sedimentation of iron in the pancreas, liver, heart, pituitary and joints, though it can establish multiorgan involvements. We present a case of TFR2 (type 3) HH who had minor α-thalassemia and uncontrolled diabetes mellitus, and discuss the clinical presentation and patient management. A 33-year-old man with type 3 HH and alpha-thalassemia trait, presented with uncon- trolled diabetes mellitus, skin hyperpigmentation and hypogonadism. The patient had high blood glucose ,despite the administration of 80 units of Glargine and 80 units of Aspart insulins per day, but after changing them into human insulins, his diabetes mellitus was surprisingly controlled with only 32 units of NPH and 18 units of Regular insulins. Furthermore, he was treated with testosterone (due to hypogonadism) and Deferasirox (due to iron overload).

    Keywords: Hemochromatosis, Alpha-thalassemia, Diabetes mellitus, Hypogonadism
  • Abbas Tafakhori, Alireza Soltani Khaboushan, Aydin Taghilou, Sajad Shafiee

    A 20-year-old woman presented with left eye ptosis without any headache and pupillary dysfunctions. After the radiological examination, the oculomotor nerve compression was detected in the interpeduncular space by the posterior communicating artery (PCoA) with normal size and shape. The patient underwent frontotemporal craniotomy, and during the surgery, the nerve was detached from the PCoA. Immediately after surgery, all symptoms disappeared. Although oculomotor nerve palsy (ONP) owing to internal carotid-PCoA aneurysm is common, vascular compression due to a non- aneurysmal PCoA is very rare. To the extent of our knowledge, this is the first case in which a slightly displaced, otherwise normal, PCoA causes ONP without any pupillary involvement. After ruling out an aneurysmal artery, this should be considered as one of the possible causes of the ONP.

    Keywords: Hemochromatosis, Alpha-thalassemia, Diabetes mellitus, Hypogonadism
  • Arash Pouladi, Reza Ghanei Gheshlagh, Nahid Kahrizi, Daem Roshani, Chia Jalali, Borhan Moradveisi*
    Background

    In various cancers, Ganoderic Acid A (GAA), an active triterpenoid derived from Ganoderma

    Background

    Thalassemia refers to a category of inherited disorders resulting from defects in synthesizing one or several chains of hemoglobin (Hb). The present study aimed to determine the frequency of alpha and beta-thalassemia mutations in Kurdistan province, Iran.

    Materials and Methods

    In this retrospective cross-sectional study, the laboratory data of 340 patients with thalassemia (170 females and 170 males), who were candidates for genetic testing in Kurdistan province, were examined over ten years (2006-2016). The participants were Kurd couples selected from the premarital health screening program.

    Results

    In this demographic study, 20 beta mutations and nine alpha mutations were identified. Among the beta-thalassemia mutations, intervening sequence or intron No. 2- first nucleotide change as splice site mutation (IVS-II-1) (26.1%), codons 8/9 (14.8%), and intervening sequence or intron No. 1- first nucleotide (IVS-I-1) (12.2%) change as splice site mutation), had the highest frequency rates, respectively, constituting 53% of the beta mutations. In addition, α3.7(82.7%), -α4.2(8.3%), and --MED (Mediterranean deletion) (3.75%) were the most frequent alpha mutations, which constituted more than 90% of the alpha mutations.

    Conclusion

    According to the results, the most frequent mutations in the HBB gene are IVS-II-1, Codons 8/9, and IVS-I-1, and in the HBA gene are α3.7, -α4.2, and –MED in Kurdistan province. In addition, the role of race and ethnicity as significant, influential factors in thalassemia was observable in the findings. The obtained results also indicated the communication pattern between the studied region's populations. Identifying common thalassemia mutations in an area could greatly benefit the early detection of thalassemia carriers in genetic laboratories and enhance thalassemia prevention programs.

    Keywords: Alpha Thalassemia, Beta Thalassemia, Iran, Mutation
  • Nailil Husna, Niken Satuti Nur Handayani*
    Background

    alpha-Thalassemia is caused primarily by deletions of one to two alpha-globin genes and is characterized by absent or deficient production of alpha-globin protein. The South-East Asia (SEA) deletion, 3.7-kb and 4.2-kb deletions are the most common causes. The present study aimed to observe the molecular characteristics of this common alpha-Thalassemia deletions and analyse its haematological parameter.

    Methods

    Blood samples from 173 healthy volunteers from thalassemia carrier screening in Yogyakarta Special Region were used. Haematological parameters were analysed and used to predict the carrier subjects. Genotype of suspected carriers was determined using multiplex gap-polymerase chain reaction and its haematological parameters were compared. The boundary site of each deletion was determined by analysing the DNA sequences.

    Results

    Seventeen (9.8%) of the volunteers were confirmed to have alpha-Thalassemia trait. Of these, four genotypes were identified namely –α3.7/αα (58.8%), –α4.2/αα (5.9%), –α3.7/–α4.2 (5.9%) and – –SEA/αα (29.4%). The 5′ and 3′ breakpoints of SEA deletion were located at nt165396 and  nt184700 of chromosome 16, respectively. The breakpoint regions of 3.7-kb deletion were 176-bp long, whereas for 4.2-kb deletion were 321-bp long. The haematological comparison between normal and those with alpha-Thalassemia trait genotype indicated a significant difference in mean corpuscular volume (MCV) (p< 0.001) and mean corpuscular haemoglobin (MCH) (p< 0.001). As for identifying the number of defective genes, MCH parameter was more reliable (p= 0.003).

    Conclusions

    The resultant molecular and haematological features provide insight and direction for future thalassemia screening program in the region.

    Keywords: Allelic Imbalance, Alpha-Thalassemia, Indonesia, Multiplex Polymerase Chain Reaction, Sequence Deletion
  • Yong-Zhi Lun *, Wei Qiu, Wenqi Zhao, Hua Lin, Mintao Zhong, Jie Sun
    Background

    At present, there is no report that the intestinal flora of pregnant women with mild thalassemia is different from that of healthy pregnant women.

    Objectives

    This study compared the composition and changes of the intestinal flora of pregnant women with mild thalassemia to those of healthy pregnant women using metagenomic sequencing technology and evaluated the potential microecological risk for pregnant women and the fetus.

    Methods

    The present study was carried out on 14 mild thalassemia pregnant women with similar backgrounds in the Affiliated Hospital of Putian University, Fujian, China. In the same period, 6 healthy pregnant women were selected as the control group. The genomic deoxyribonucleic acid was extracted from the sable stool samples of pregnant women. Illumina HiSeq sequencing technology was adopted after library preparation. Prodigal software (ver 2.6.3, Salmon software (ver 1.6.0, and Kraken software (ver 2) were used to analyze the sequence data. Moreover, analysis of variance and Duncan’s multiple-comparison test or Wilcoxon rank-sum test were used as statistical methods.

    Results

    The characteristics of the intestinal flora of pregnant women with mild thalassemia differed significantly from those of healthy pregnant women, showing an increase in some conditionally pathogenic bacteria (e.g., Prevotella stercorea rose and Escherichia coli) and a decrease in some probiotic bacteria, which might affect pregnant women and cause physiological function damage to their offspring by changing metabolic pathways; however, further validation is needed.

    Conclusions

    The diversity and composition of intestinal flora in pregnant women with mild thalassemia vary significantly from those in healthy pregnant women, especially at the genus and species levels, representing more profound alterations in intestinal microecology.

    Keywords: Intestinal Flora, Metagenomics, Pregnant Women, Beta-thalassemia, Alpha-thalassemia
  • Fathi Afshin, Mehdi Valizadeh*, Rouhallah Moradpoor, Mahshid Damandan, Firouz Amani
    Background and Objective

    Alpha-thalassemia (α-thal) appears to be the most common monogenic disorder worldwide. The diagnosis of α-thalassemia depends on the detection of Hemoglobin Bart (Hb Bart's) in newborns, which indicates one or more defective or absent α-globin genes. In addition, in patients with Hemoglobin H (Hb H), the Hb H range usually varies between 7-10 g / dL. Therefore, tracking Hb Bart's and Hb H can be useful in diagnosing thalassemia α. This study was performed to evaluate Hb Bart's and Hb H in infants with α thalassemia in Ardabil province, northwestern Iran.

    Material and Methods

    In this cross-sectional descriptive study, 33 infants with alpha thalassemia mutation, including infants born in Ardabil province, Iran in the years 2020 to 2019. Hemoglobin analysis was performed by capillary electrophoresis system.

    Results

    Hb H and Hb Bart's were detected in only two cases (6%) and three cases (9%). In this study, only 5 patients (15.15) were observable by detection of Hb Bart's and Hb H levels by electrophoresis. In cases of Hb Bart disease, -α3.7 was the most common genotype. Therefore, most infants with alpha thalassemia were lost when electrophoresis alone was used.

    Conclusion

    This study showed that molecular analysis of Hb Bart's newborns is necessary to confirm α-thalassemia. Capillary electrophoresis is a way to prevent the diagnosis of rare Hb H and Bart's disease.

    Keywords: alpha-Thalassemia, hemoglobin Bart's, Hemoglobin H, Electrophoresis Capillary
  • Jalal Pouranfard, Farzad Vafaei, Sajad Afrouz*, Mohsen Rezaeian
    Background

    Thalassemia is the most common hereditary anemia which has a relatively high prevalence in Iran. In most cases, more than 300 mutations have been identified, which affect genes of alpha and beta globin chains and lead to lack of production or reduction of chains. Iran’s population is composed of different ethnic groups, thus, determining the frequency and distribution of these mutations is essential in different parts of the country. We aimed to assess Thalassemia gene mutations in Kohgiluyeh and Boyer-Ahmad province.

    Methods

    In this cross-sectional study, 656 couples were selected and their Genomic DNA was extracted by DNA extraction kit method and tested using multiplex gap-polymerase chain reaction (gap-PCR), amplification refractory mutation system-PCR (ARMS-PCR), and DNA sequencing. Finally all data were analyzed using the SPSS version 17 software.

    Results

    More than 13 mutations were found on α-globin genes. Based on gene frequency, the most common mutant allele was –α3.7/αα (rightward) (71.3%) followed by the two gene deletion −α3.7/−α3.7 (2.5%). Other common mutations were polyA2 (2.1%), αcodon 19α/αα (1.7%), –α3.7/αα/–α3.7/αα (1.5%), – (α) 20.5 (0.6%), α−5 nt/αα (0.5%), and other mutations. In this study, more than 21 mutations were identified on beta thalassemia gene. The most common mutation was CD36- /37 (-T) (19.8%). Other common reported mutations included IVSII-1 (G>A) (9.5%), IVS I-110 (G>A) (4.7%), IVSII-745 (C>G) (4.4%), codon 82/83(-G) (3.7%), FSC 8/9 (+G) (1.7%), Codon19(1.5%), 25 bp deletion (beta0) (1.5%), IVS-I-116 (T>G) (1.4%), IVSI-6 (G>C) (1.1%), codon 5 (-CT) (0.9%), codon 88 (-C) (0.5%), and IVSI-1(G>A) (0.3%).

    Conclusion

    The frequencies of these mutations were different in various parts of the country. Therefore, defining thalassemia mutations is necessary to establish prenatal diagnosis programs leading to lower medical cost in Kohgiluyeh and Boyerahmad province.

    Keywords: Alpha thalassemia, beta thalassemia, Mutation
  • Masoomeh Sayahi, Farideh Ghanbari Mardasi *, Masoomeh Salehi Kambo
    Background
    Thalassemia and other hemoglobinopathies are inherited disorders that result from genetic defects causing deficient synthesis of hemoglobin polypeptide chains. This study was done to determine the prevalence and to study the complete spectrum of alpha and beta thalassemia gene mutations in the voluntary hemoglobinopathy carrier couples-to-be referred to health centers of Shoushtar city, located in the north Khuzestan province.
    Methods
    Subjects referred to health centers of the city of Shoushtar during 2011 - 2016 were evaluated for the presence of thalassemia minor. After that, alpha and beta thalassemia gene mutations were explored in suspected couples. The samples that underwent PND and diagnosing of causative mutational genes by chorionic villus sampling (CVS) through amniocentesis plus direct or indirect genetic testing at first trimester of pregnancy were proved to be a carrier for alpha thalassemia, beta thalassemia, or other hemoglobinapathies.
    Results
    The mutations for 111/165 (67%) of beta thalassemia chromosomes (19 different mutations) were identified. Of which, IVSII-1 (G > A) and CD 36 - 37 (-T) mutations showed the highest frequency (23.4 for each one) followed by IVSI-110 (G > A) (10%), CD 82-83 (-G) (9%), and -110 (C > T) (7.2%). Among the alpha thalassemia subjects (54/165 (33%)), the -α3.7 mutation was the most common (79/6%) determinant identified in the city of Shoushtar. From 48 voluntary carrier couples who underwent PND, 10 (20.8%) couples were proved to have fetuses with major beta thalassemia; pregnancy termination was done for them.
    Conclusions
    These data suggest that the spectrum of mutations in the city of Shoushtar differs from those reported from other parts of Iran. Therefore, in order to save the time and cost, it is recommended that for the prenatal diagnosis of thalassemia in the city of Shoushtar, analysis of common mutations should be considered as a front line screening strategy. Prenatal diagnosing in this survey demonstrated that beta thalassemia was the most common accounting for all disorders.
    Keywords: Prenatal Diagnosis, Alpha Thalassemia, Beta Thalassemia, Hemoglobinopathy
  • Azam Moosavi *, Ali M. Ardekani
    Background
    β-thalassemia is the most common monogenic disorder in Iran, and one of the challenges in the screening of the carriers is the coinheritance of α-thalassemia mutations. In the view of high prevalence of α-thalassemia mutations in many parts of the country, the aim of this study was to determine the carrier frequency of common alpha deletions, as a secondary modifier in clinical manifestations of beta thalassemia, in known beta-thalassemia carriers and some hematology parameter changes.
    Methods
    The study included families referred from different primary health care centers with microcytic hypochromic anemia [MCV3.4%]. Genomic DNA was extracted from peripheral blood leukocytes by salting out method. For common β-globin gene mutation analysis, amplification refractory mutation system- polymerase chain reaction (ARMS-PCR) and for rare β-thal alleles, DNA sequencing were used. Also, for investigation of common α-globin gene cluster deletions (-α3.7, -α4.2, --MED and -α20.5), multiplex Gap-PCR was performed.
    Results
    Among 227 β-thalassemia minor individuals studied, α-globin gene deletions were found in 43 cases: 37 heterozygote -α3.7 (16.3%), 5 homo -α3.7 (2.2%) and 1 --MED (0.44%). Also, the co-inheritance of α-globin gene deletion and triplication was not found in the studied individuals.
    Conclusion
    Although it is highly recommended that physicians and genetic counselors involved in the screening program of beta-thal major in the country consider this phenomenon because of high prevalence of this coinheritance, hematologic indices changes are very slight.
    Keywords: Alpha thalassemia, Beta thalassemia, Hypochromic anemia
  • Hossein Jalali, Mehrnoush Kosaryan, Mohammad Reza Mahdavi, Mehrad Mahdavi
    Alpha Thalassemia is one of the most prevalent disorders worldwide with a [T1] high carrier rate in Mazandaran province (north of Iran). Carriers of --MED double gene deletion are at risk of having a child with hemoglobin haemoglobin[T2] H (HbH) disease, if they marry a silent carrier. Co-inheritance of αααAnti3.7 triplication that cannot be detected using hematological indices and β-globin gene mutations, in heterozygote states, leads to intermediate form of thalassemia. Using precise molecular analysis, the mutations that do not change the hematological parameters can be identified. The diagnosis of these mutations is important in screening programs. Multiplex Gap-PCR and reverse hybridization assay analysis were applied for the detection of mutations on α and β-globin genes in a patient with abnormal hematological[T3] indices from Sari at 2016. A rare co-inheritance of --MED double gene deletion and αααAnti3.7 triplication was identified. The presented case can be at risk of having a child with HbH disease and thalassemia intermedia. So, the presented case shows the [T4] importance of precise molecular analysis in premarital screening in order to prevent having a child with thalassemia.
    Keywords: Alpha Thalassemia, αααanti3.7 triplication, --MED double gene deletion
  • Maryam Helali, Samira Esmaeili Reykandeh, Shaban Alizadeh, Zahra Kashani Khatib, Javad Razavian, Zahra Sadat Abtahi, Azita Azarkeivan
    Background
    Alpha-thalassemia syndrome includes a group of hereditary anemia in which expression of alpha globin chains is decreased or absent. Impaired RBC in patients with thalassemia causes vessel involvement and endothelial cell vessel disturbance. Vascular Endothelial Growth Factor (VEGF) is the most important regulator for endothelial cell proliferation. So, the aim of this study is to compare the serum VEGF levels in patients with alpha thalassemia and normal control group.
    Materials And Methods
    This case-control study was conducted on 17 patients with alpha thalassemia and 40 healthy people. Serum VEGF levels were measured by enzyme-linked immune sorbent assay (ELISA) kit. Then statistical analysis of results were performed using SPSS 16, value of P
    Results
    Mean serum VEGF levels in case and control groups were 2294.19±1552.39 and 598.09±988.17pg/ml, respectively. Serum VEGF levels were higher in patients with alpha thalassemia (P
    Conclusion
    Our study revealed that patients with alpha thalassemia have elevated levels of serum VEGF than normal control group. Further studies with larger sample size are recommended to confirm these observations.
    Keywords: Alpha Thalassemia, Vascular Endothelial Growth Factor(VEGF), Angiogenesis
  • سجاد افروز، محمد امین قطعی *، محمد ذوالعدل، محمدحسین سنگتراش، علیرضا عوض پور
    مقدمه
    تالاسمی بیماری با توارث اتوزومی مغلوب که به علت اختلال در واریانت های ساختاری یا سنتز زنجیره های گلوبینی ایجاد می شود. غربالگری بیماری تالاسمی در داوطلبین ازدواج، فرصتی مناسب جهت پیش گیری و کنترل این بیماری است. با توجه به اهمیت تغییرات اندکس های خونی این مبتلایان، این مطالعه با هدف مقایسه تغییرات میانگین اندکس های خونی در داوطلبین ازدواج استان کهگیلویه و بویراحمد با نوع تالاسمی انجام شد.
    مواد و روش ها
    در این مطالعه توصیفی- مقطعی نتایج آنالیز ژنتیکی با روش GAP-PCR متضمن نوع تالاسمی و مقادیر ایندکس های خونی MCV، MCH،HBA2 وRBC مربوط به 111 نفر از داوطلبین ازدواج مراجعه کننده به مراکز بهداشت استان به همراه مشخصات جمعیت شناختی آنها وارد نرم افزار SPSS 17 شده و با استفاده از آزمون های Anova و ضریب همبستگی پیرسون ،مورد تجزیه و تحلیل قرار گرفتند.
    یافته ها
    تالاسمی آلفا با 4/78 درصد، غیر آلفا-بتا با 9درصد و بتا با 1/8 درصد بیشترین فراوانی را داشتند. میانگین اندکس های خونی داوطلبین ازدواج تالاسمیک HBA2 با 75/0±77/2،MCV با 58/5 ±62/75، MCH با 40/2±87/23 وRBC با 62/0±61/5 بود. میانگین MCV در مبتلایان به تالاسمی آلفا بطور معنادار آماری بیشتر از این شاخص در مبتلایان به تالاسمی بتا بود. تفاوت میانگین اندکس MCV در بیماران تالاسمی آلفا و بیماران دچار تالاسمی غیر آلفا/بتا معنادار نبود. تفاوت میانگینMCV برای تالاسمی بتا با هر دو تالاسمی آلفا و غیر آلفا/بتا معنادار بود. برای اندکس هایMCH و HBA2، نتایج مشابه با MCV بدست آمد در حالی که تفاوت میانگین RBC برای هیچ یک از انواع تالاسمی معنادار نبود. در تمامی مبتلایان به انواع تالاسمی بین MCV و MCH همبستگی مستقیم معنادار وجود داشت. در مبتلایان به آلفا تالاسمی بین این دو اندکس با RBC همبستگی معنادار معکوس بود (0/01 p=).
    نتیجه گیری
    تفاوت معنا دار میانگین اندکس های خون MCV، MCH و HBA2 در مبتلایان به تالاسمی آلفا با بتا و تالاسمی غیر آلفا/بتا با بتا و بتا تالاسمی با هر دو می تواند به عنوان یک شاخص پیشگویی کننده در تشخیص بالینی انواع تالاسمی در استان عمل نماید.
    کلید واژگان: تالاسمی آلفا, تالاسمی بتا, اندکس های خونی, کهگیلویه و بویراحمد
    Sajad Afrouz, Mohammad Amin Ghatee *, Mohammad Zoladl, Mohammad Hossain Sangtarash, Ali Reza Avazpour
    Introduction
    Thalassemia is an inherited autosomal recessive anemia caused by structural variations or abnormalities in globin chain synthesis. The screening of thalassemia in marriage candidates is a suitable opportunity for prevention and control of this disease. Regarding hematologic indices variations in above-mentioned patients, this study was conducted to compare the hematological indices variations in types of Thalassemia in marriage candidate patients in Kohgiluye & Boyerahmad province in 1392.
    Method
    In this cross-sectional study, the results of the genetic analysis by GAP-PCR method and hematological indices including MCV, MCH, HGA2 and RBC of 111 thalassemic marriage candidates who referred to health centers, along with their demographic data was analysed with descriptive statistics and inferential statistics Anova and pirson"s correlation, by SPSS 17 software.
    Results
    Alpha thalassemia (78/4 percent), non-alpha-beta thalassemia (9 percent) and beta thalassemia (8.1 percent) were the most frequent types, respectively. The average of hematological indices were 2/77 ± 0/75, 75/62 ± 5/58, 23/87 ± 2/40 5/61 ± 0/62 for HbA2, MCV, MCH and RBC, respectively. Alpha thalassemia patients showed higher MCV average in comparison to beta thalassemia cases. The difference of average of MCV between patients with alpha-thalassemia and patients with non-alpha/beta was not statistically significant. MCV average in Beta thalassemia was not different with both Alpha thalassemia and non-alpha/beta thalassemia. MCH and HgA2 difference between different thalassemia types was matched with MCV but RBC average difference was not significant for any types of thalassemia. There was a direct significant correlation between MCV and MCH for all types of thalassemia. MCV and MCH indices averages have inversely correlated with RBC In patients with alpha thalassemia (p =0/01).
    Conclusion
    Ddifference of average of blood parameters including MCV, MCH and HgA2 between beta thalassemia cases with alpha, non-alpha-beta thalassemia patients with beta thalassemia cases, and beta thalassemia with both alpha and non-alpha-beta thalassemia can be used as a predictive marker for clinical diagnosis types of thalassemia among Kohgiluye and Boyerahmad province patients.
    Keywords: Alpha thalassemia, Beta thalassemia, Blood indices, Kohgiluyeh, amp, Boyer Ahmad
  • محمدرضا مهدوی، مهرنوش کوثریان، حسین کرمی، مهراد مهدوی، حسین جلالی، پیام روشن *
    زمینه و هدف
    بیماری تالاسمی آلفا شایع ترین نوع هموگلوبینوپاتی در جهان است و ممکن است بیمار مبتلا علایم بالینی متنوعی را از کم خونی بدون علامت گرفته تا کم خونی شدید منجر به مرگ تجربه کند. این مطالعه به منظور ارزیابی فراوانی ناقلین جهش های شایع ژن آلفاگلوبین در نوزادان متولد ساری انجام گردید.
    روش بررسی
    در این مطالعه توصیفی 412 نمونه خون بند ناف نوزادان متولد بیمارستان امیر مازندرانی شهر ساری در سال 1391 به طور تصادفی انتخاب گردید. سپس DNA ژنومی از خون آنان به روش استاندارد فنل- کلروفرم استخراج گردید. با استفاده از تکنیک های Multiplex Gap- PCR و PCR-RFLP وجود سه جهش حذفی، یک تریپلیکیشن و یک جهش نقطه ای ارزیابی شد.
    یافته ها
    فراوانی آللی مجموع کروموزوم های بررسی شده برابر 0.0825 به دست آمد. جهش حذفی –α3.7 با فراوانی آللی 0.0485 دارای بیشترین فراوانی آللی در 824 کروموزوم مورد بررسی بود. فراوانی آللی جهش های –α4.2، αααanti3.7 تریپلیکیشن و α-5nt به ترتیب 0.0206، 0.0109 و 0.0024 تعیین شد. هیچیک از نوزادان حامل جهش دو حذفی –Med نداشتند.
    نتیجه گیری
    در اکثر نوزادان مبتلا تنها یک نسخه از ژن آلفاگلوبین حذف شده و یا دارای نقص بود که این افراد بدون مشکل قادر به ادامه زندگی هستند. جهش دو حذفی –Med در هیچیک از نوزادان یافت نشد که نشان می دهد احتمال تولد نوزاد مبتلا به بیماری Hb H در منطقه پایین است.
    کلید واژگان: آلفاتالاسمی, آلفاگلوبین, جهش ژنی, نوزاد
    Mahdavi Mr, Kosaryan M., Karami H., Mahdavi M., Jalali H., Roshan P.*
    Background And Objective
    Alpha Thalassemia is one of the most prevalent hemaglobinophaties worldwide. Alpha thalasseima patients may represent wide spectrum of symptoms ranging from asymptomatic to severe life threatening anemia. This study was done to assess the carrier frequency of alpha globin gene mutations among newborns in north of Iran.
    Methods
    In this descriptive study, 412 cord blood samples of neonate from Amir Mazandari hospitali were randomly selected during 2012. Genomic DNA was extracted using phenol-chloroform method. Multiplex Gap- PCR and PCR-RFLP methods were applied in order to detect three common gene deletions, one triplication and one point mutation.
    Results
    Total allelic frequency of investigated mutations was 0.0825. The -α3.7 deletion with allelic frequency of 0.0485 was the most prevalent mutation among 412 neonates. Allelic frequencies of -α4.2, αααanti3.7 triplication and α-5nt mutations were 0.0206, 0.0109 and 0.0024 respectively and -Med double gene deletion was not detected.
    Conclusion
    Most mutated cases had single gene deletion that is asymptomatic while -Med double gene deletion was not detected among the neonates. Therefore, there is low probability of a child birth with Hb H disorder in the region.
    Keywords: Alpha Thalassemia, Alpha globin, Gene Mutation, Newborn, Iran
  • لطیفه محمد پور، محمد صادق فلاح، فاطمه کشاورزی، سیروس زینلی، بایزید قادری، آزاد فتاحی راد، رضا اکرمی پور، سارا آزادمهر
    زمینه و هدف
    آلفاتالاسمی یک بیماری ژنتیکی با وراثت اتوزومی مغلوب، همراه با کاهش یا عدم ساخت زنجیره های پلی پپتیدی آلفا گلوبین است. فرم شدید بیماری آلفا تالاسمی، بیماری H disease می باشد که حاصل غیر فعال شدن 3 ژن آلفا در بیمار است. این مطالعه به منظور شناسایی ژنوتیپ مبتلا یان به H بر روی تعدادی از بیماران وابسته به خون مراجعه کننده به مراکز درمانی استان های کردستان و کرمانشاه انجام شد.
    روش بررسی
    در یک مطالعه ی توصیفی 110 بیمار مبتلا به آنمی میکروستیک و هیپوکرومیک مورد بررسی قرار گرفتند. بر اساس نتایج شمارش سلول های قرمز خون و الکتروفورز هموگلوبین فرد بیمار قبل از تزریق خون و یا والدین فرد بیمار، افراد با تشخیص آلفا تالاسمی انتخاب و مورد بررسی مولکولی قرار گرفتند DNA به روشsalting out استخراج گردید. جهش های حذفی شایع با روش multiplex PCR و جهش های نقطه ای با تعیین توالی مستقیم به روش sanger بررسی گردید.
    یافته ها
    در 12 بیمار با تشخیص تالاسمی آلفا 5 مورد حذف دو ژنی Med (8/20 درصد)، 4 مورد حذف تک ژنی α3.7 (6/6 درصد)، 3 مورد حذف دو ژنی20.5 (5/12درصد)، 3 مورد جهش نقطه ای polyA1 (5/12 درصد)، 2 مورد جهش نقطه ای Cd59 (3/8 درصد) و 2 مورد جهش نقطه ای IVSI(-5nt) (3/8 درصد) بدست آمد. 4 نفر از بیماران واجد بیماری H از نوع حذفی (α-/–)، 3 مورد بیماری H از نوع غیرحذفی (ααT/–) و 2 مورد هم واجد دو جهش نقطه ای (ααT/ααT) بودند. 2 نفر از بیماران وابسته به تزریق خون بودند و ژنوتیپ فردی که به صورت منظم خون تزریق می نمود، CD59αα/MED–تشخیص داده شد. فردی که به صورت نامنظم و بر حسب نیاز چند بار تزریق خون انجام داده بود دارای ژنوتیپ α3.7-/α20.5– بود. در 7 مورد از بیماران بزرگی طحال مشاهده شد و در 3 نفر دیگر قبلا، عمل طحال برداری انجام شده بود.
    نتیجه گیری
    نتایج بدست آمده نشان از تنوع جهش های آلفا گلوبین در گروه مورد مطالعه و اهمیت جهش های نقطه ای در بیماری H داشت. هرچند تعیین رابطه فنوتیپ و ژنوتیپ دقیق تر و تشخیص موارد بیماری H که نیاز به تشخیص قبل از تولد دارند ضرورت انجام مطالعه ای وسیع تر در سطح ملی را می طلبد.
    کلید واژگان: آلفا تالاسمی, بیماری H, کردستان, کرمانشاه
    Latifeh Mohammadpour, Dr Mohammad Sadegh Fallah, Dr Fatemeh Keshavarzi, Dr Siroos Zeinali, Dr Bayazeed Ghaderi, Dr Azad Fattahy Rad, Dr Reza Akramipour, Sara Azadmehr
    Background And Aim
    Alpha Thalassemia is an autosomal recessive genetic disease by reduced or absent synthesis of alpha globin polypeptide chains. One of the severe forms of disease with 3 alpha globin genes inactivation is H disease. In this study genotype of H disease was assessed in some patients with blood abnormalities referred to hospitals of Kermanshah and Kurdistan provinces.
    Materials And Method
    In this descriptive research, 110 patients with microcytic and hypochromic anemia were recruited. Based on CBC and hemoglobin electro‌phoresis tests in patients before blood transfusion or their parents, alpha thalassemia was diagnosed. DNA was extracted by salting out method. The common deletions, alpha globin point mutations and direct sequencing were investigated using multiplex PCR and Sanger methods respectively.
    Results
    In twelve alpha thalassemia patients, it has been shown the deletion mutations of --Med in 5 patients (20.8%), -α3.7 in 4 patients (6.6%) and -α20.5 in 3 patients (12.5%) and also point mutations polyA1 in 3 patients (12.5%),-αcd59 in 2 patients (8.3%) and -αIVSI (-5nt) in 2 patients (8.3%). In 4 cases deletion (-α/--) and in 3 cases (40%) non-deletion H disease (--/ααT) were diagnosed. Two cases showed point mutation of ααT/ααT. Two patients were blood-transfusion dependent. The first one who received regu‌lar blood monthly, showed --Med/αcd59 genotype. The second one with -α20.5/-α3.7 genotype received blood occasionally. In 7 patient’s enlargement of spleen was observed and in 3 patients splenectomy was performed earlier.
    Conclusion
    The results showed the genetic diversity in alpha-globin and the importance of point mutations in the H disease. However, further study should be done to determine the accurate genotype and phenotype relationship and to diagnose of H disease in prenatal cases.
    Keywords: : Alpha Thalassemia, H disease, Kurdistan, Kermanshah
  • Ebrahim Miri, Moghaddam, Abass Nikravesh, Negin Gasemzadeh, Mahin Badaksh, Nahid Rakhshi
    Background
    Alpha thalassemia (α-thal) is one of the most common hemoglobinopathies worldwide. The aim of this study was to investigate the spectrum of α-thal mutations among premarital Baluch couples in southeastern Iran. Subjects and
    Methods
    We assessed 1215 individuals by multiplex gap polymerase chain reaction (gap-PCR) and amplification refractory mutation system (ARMS-PCR).
    Results
    Of the 1215 participants with mean age of 23±5.7 years, 62.3% lived in urban areas, and the rate of consanguineous marriage was 68.1%. Five mutations were identified, the most frequent one was –α3.7 (rightward) with a frequency of 76.5%, followed by α−5 nt (16.8%), α2/ Codon 19(-G) (4%), –α4.2 (leftward)(2.4%), – –MED(0.3%) among mutated alleles of the α -globin gene.
    Conclusion
    Knowing the alpha-genotype is helpful for genetic counseling, microcytic anemia discrimination and hemoglobinopathy prevention.
    Keywords: Alpha thalassemia, prevalence, mutation, Baluch, Iran
  • محمدرضا مهدوی، محمدطاهر حجتی، پیام روشن
    تالاسمی، کم خونی همولیتیک شدیدا پیشرونده با توارث ناهمگون و شدت های مختلف می باشد. در تالاسمی کاهش ساخت هر کدام از زنجیره های گلوبین، موجب به هم خوردن نسبت میان زنجیره های آلفا و بتا می گردد و رسوب زنجیره های جفت نشده در گلبول های قرمز آغاز مشکلات بیماران تالاسمی می باشد. علی رغم این که در حال حاضر تزریق واحدهای خونی سازگار مهم ترین روش درمانی در این بیماری می باشد، عمده عوارض به وجود آمده در این بیماران از تزریق واحدهای خونی می باشد که مهم ترین آن ها اضافه بار آهن می باشد که موجب اختلال در عملکرد بافت های آسیب دیده از این عارضه مثل اختلالات قلبی و عروقی، اندوکرین و انعقادی می گردد. سه علت عمده برای پدیده اضافه بار آهن را می توان از اریتروپویز غیر موثر، تزریق خون های متعدد و افزایش جذب روده ای آهن نام برد. درمان توامان تزریق خون و آهن زدایی جهت جلوگیری از رسوب ذرات آهن در بافت های حیاتی، باعث افزایش چشم گیر طول عمر بیماران تالاسمی شده است. امروزه پیوند مغزاستخوان، تعیین مولکولی وجود آنتی ژن های سطحی گلبول های قرمز جهت تزریق واحدهای خونی هرچه سازگارتر و استفاده از فراورده های دارویی جدید در کاهش وابستگی این بیماران به خون در درمان بیماران تالاسمی می تواند امید بخش باشد.
    کلید واژگان: تالاسمی آلفا, تالاسمی بتا, کم خونی همولیتیک
    Mohammad Reza Mahdavi, Mohammad Taher Hojjati, Payam Roshan
    Thalassemia is a highly progressive hemolytic anemia with different levels of complexity in patients. In thalassemia، reduced level of synthesis of hemoglobin chains results in an imbalanced production of alpha and beta globin chains، and sedimentation of unpaired chains inside red blood cells is the beginning of complications among thalassemia patients. Nowadays compatible blood transfusion is the main approach in treatment of the disease، however، major problems of the patients، results from this treatment، and the most pronounced one is iron overload، which influences the function of different organs including cardiovascular، endocrine and coagulation systems. The major causes of iron overload are non-effective erythropoiesis، frequent blood transfusion، and increased iron absorption through intestine. In order to prevent iron deposition in vital organs، blood transfusions and iron chelation therapy could significantly increase the life expectancy of thalassemia patients. Today، bone marrow transplantation، molecular identification of RBC surface antigens to find the most compatible blood for the patient، and replacing old medications with newly developed ones، are very promising in reducing the dependence of patients on blood transfusion.
    Keywords: Alpha thalassemia, beta thalassemia, hemolytic anemia
  • میترا رمضانی، یدالله رمضانی، داود امیریان مجد، منصور صالحی
    مقدمه
    در سال های اخیر در ایران تالاسمی آلفا و بتا قبل از ازدواج در زوجین غربالگری می شود. همان طور که می دانیم شکل شدید تالاسمی آلفا در جنین به صورت هیدروپس فتالیس خود را نشان می دهد و باعث مرگ جنین می شود. در این مطالعه میزان نیاز به تشخیص پیش از تولد جهت تشخیص هیدروپس فتالیس را در بین زوج هایی که از طرف مراکز بهداشتی به آزمایشگاه ژنتیک بیمارستان الزهرا (س) فرستاده شدند، بررسی شد و میزان هزینه-اثربخشی این غربالگری تعیین شد.
    روش ها
    این مطالعه یک مطالعه ی توصیفی- تحلیلی بود که از بهمن 1388 تا خرداد 1391 انجام شد. جمعیت مورد مطالعه کلیه ی افرادی بودند که از طرف مراکز بهداشت با MCV (Mean corpuscular volume) کمتر از 80 و MCH (Mean corpuscular hemoglobin) کمتر از 27 و HbA2 (Hemoglobin A2) کمتر از 5/2 به آزمایشگاه ژنتیک بیمارستان الزهرا (س) ارجاع شده بودند و با یک ماه مصرف قرص آهن، اندکس های خونی آن ها به حد طبیعی نرسیده بود. DNA این افراد با روشPCR (Polymerase chain reaction) تکثیر شد و توسط ژل الکتروفورز تحت بررسی قرار گرفت.
    یافته ها
    در مجموع 642 زوج معیارهای ورود به مطالعه را داشتند. از این تعداد 75 زوج (6/11 درصد) ژنوتیپ بتا- بتا و 343 زوج (4/53 درصد) ژنوتیپ آلفا- آلفا و 224 زوج (8/34 درصد) ژنوتیپ آلفا- بتا داشتند. از 343 زوج با ژنوتیپ آلفا- آلفا، 3 زوج (87/0 درصد) نیاز به تشخیص پیش از تولد پیدا کردند و از این تعداد فقط یکی از جنین ها مبتلا به هیدروپس شد.
    نتیجه گیری
    مقرون به صرفه بودن غربالگری تالاسمی آلفا در زوج های آماده برای ازدواج نیاز به بررسی های بیشتری در سطح کشور دارد چون تعداد جنین هایی که نیاز به تشخیص پیش از تولد پیدا می کنند به قدری کم است که قابل چشم پوشی می باشد. ضمن این که به طور معمول جنین های مبتلا به هیدروپس زنده نمی مانند و سقط می شوند و بنابراین ابتلای کودک به تالاسمی ماژور مشکل ساز نخواهد بود. بنابراین توصیه می شود که در مورد لزوم غربالگری تالاسمی آلفا در سطح کشور مطالعات بیشتری صورت بگیرد.
    کلید واژگان: تالاسمی آلفا, تشخیص پیش از تولد
    Mitra Ramezani, Yadollah Ramezani, Davood Amirian, Mansoor Salehi
    Background
    In recent years, both alpha and beta thalassemia have been screened in couples before marriage. The severe form of alpha thalassemia, i.e. hydrops fetalis, is found in fetuses and causes fetal death. We tried to determine the need for prenatal diagnosis of hydrops fetalis among couples referred to Alzahra Genetic Laboratory. We also evaluated the cost-effectiveness of alpha thalassemia screening.
    Methods
    This descriptive study included all individuals that had been referred to the genetic laboratory from various health centers in Isfahan (Iran). The subjects had mean corpuscular volume less than 80 fL, mean corpuscular hemoglobin less than 27 pg, and hemoglobin A2 less than 2.5. Moreover, one month of iron supplementation had failed to normalize their blood indexes. DNA was duplicated with polymerase chain reaction and examined with gel electrophoresis.
    Findings
    During the 27 months and nine days of the study (2009-2012), 642 eligible couples were referred to Alzahra Genetic Laboratory. Of these, 75 couples (11.6%) had beta-beta genotype, 343 couples (53.4%) had alpha-alpha genotype, and 224 couples (34.8%) had genotype alpha-beta. Of the 343 couples who had alpha-alpha genotype, three couples (0.87%) required to have prenatal diagnosis.
    Conclusion
    Considering the very few fetuses that required prenatal diagnosis, the cost-effectiveness of alpha-thalassemia screening in preparing couples for marriage has to be further evaluated at the country level. On the other hand, as fetuses with hydrops will not survive and will abort (only one fetus had hydrops in this study), children with thalassemia major will not be a problem.
    Keywords: Alpha thalassemia, Prenatal diagnosis
  • Haleh Akhavan, Niaki, Reza Youssefi Kamangari, Ali Banihashemi, Vahid Kholghi Oskooei, Mandana Azizi, Ahmad Tamaddoni, Sadegh Sedaghat, Mohsen Vakili, Hassan Mahmoudi Nesheli, Soraya Shabani
    Alpha thalassemia (α-thal) is relatively common worldwide. Most carriers are defective in either one or two alpha globin genes out of four functional ones, with deletions being more common than point mutations. The hematologic features are very important for the selection of the appropriate molecular tests while determining the genotype. The aim of this study was to compare hematologic features of patients with various types of α globin mutations. Hematological indices including red blood cells (RBC), hemoglobin concentration (Hb), mean cell volume (MCV), mean cell hemoglobin (MCH), Mean corpuscular hemoglobin concentration (MCHC) and percentage of Hemoglobin (HBA1, HBA2 and HBF) of seven-hundred and twenty two patients presenting ten different α-thal genotypes were considered. All patients showed reduced MCV and/or MCH values. Moreover, MCV and MCH were lower in patients with two functional alpha globin genes in comparison to patients with one mutated alpha globin gene (P value<0.001). In conclusion, MCV and MCH values can be helpful for the selection of the appropriate molecular tests to determine the genotype of alpha thalassemia carriers.
    Keywords: Alpha thalassemia, Mean cell volume, Mean cell hemoglobin, Mutation
  • Reza Bahrami, Narjes Pishva, Mahdi Shahriari, Amir Naghshzan*
    Introduction
    Newborn screening is a systematic application of tests for early detection, diagnosis, and treatment of certain genetic or metabolic disorders that may lead to mortality and morbidity if untreated. As stated by WHO, each year over 330,000 babies are born worldwide with a severe form of hemoglobinopathy. Newborn screening for hemoglobinopathies could become one of the most important methods of decreasing mortality and morbidity and mitigating rising healthcare costs. The diversity and heterogeneous distribution of hemoglobin disorders make it necessary to develop strategies at the country level.
    Methods
    Overall, 499 healthy full term Iranian neonates were screened for hemoglobinopathies who were originated from Fars province in southern part of Iran. The screening was performed on cord blood samples collected on EDTA. Following sample collection, complete blood cell count cell indices, osmotic fragility test and hemoglobin electrophoresis were performed.
    Results
    Total prevalence of significant hematologic abnormal findings was 12.4% in this study, the most prevalent one was Alpha thalassemia (6.4%) followed by hereditary spherocytosis (4.8%), and sickle cell anemia (1.2%). The total analysis for detection of Alpha thalassemia by mean corpuscular volume (MCV) ≤ 94, mean corpuscular hemoglobin (MCH) ≤ 27, and hemoglobin level ≤ 14 indicated failure and these results were not appropriate to this discrete population.
    Conclusion
    We suggested the new cut off points for neonatal screening programs of the Iranian population be MCV≤96 and MCH ≤31 for Alpha thalassemia. A successful disease prevention strategy could lead to significant savings in spiraling healthcare costs and mitigate the scarcity of blood products. The healthcare budget savings realized from preventive screening justifies the spending on such a national thalassemia program. We recommended a neonatal screening program for southern Iranian population and also designed a new format for neonatal discharge summary.
    Keywords: Hemoglobinopathy, neonatal screening program, alpha thalassemia, hereditary spherocytosis, sickle cell anemia
نکته
  • نتایج بر اساس تاریخ انتشار مرتب شده‌اند.
  • کلیدواژه مورد نظر شما تنها در فیلد کلیدواژگان مقالات جستجو شده‌است. به منظور حذف نتایج غیر مرتبط، جستجو تنها در مقالات مجلاتی انجام شده که با مجله ماخذ هم موضوع هستند.
  • در صورتی که می‌خواهید جستجو را در همه موضوعات و با شرایط دیگر تکرار کنید به صفحه جستجوی پیشرفته مجلات مراجعه کنید.
درخواست پشتیبانی - گزارش اشکال